Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 27 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Aspirin may help some adults prevent heart attacks

The US Preventive Services Task Force (USPSTF) today strongly recommended that doctors discuss the benefits and harms of aspirin therapy with adult patients who are at increased risk of coronary heart disease (CHD).

News image

fiogf49gjkf04

Those at risk include people with unfavorable cholesterol levels (elevated total cholesterol levels and/or low levels of high-density lipoprotein cholesterol), men over age 40, postmenopausal women, and people with risk factors for CHD, such as smoking, diabetes, and hypertension.

It is known that aspirin decreases the chances of heart attacks in people who have had previous heart attacks or strokes.

The new recommendations and a background article, with a systematic review of the evidence about the harms and benefits of aspirin therapy, are published in the latest issue of the Annals of Internal Medicine.

The optimum dose of aspirin for prevention is not known, according to the USPSTF. Doses of 75 mg daily, approximately the dose in one 'baby' aspirin, appear as effective as higher doses.

Uncontrolled hypertension may lessen the benefits of aspirin in reducing CHD.

However, the Task Force pointed out aspirin's potential harmful effects.

It found good evidence that aspirin increases the incidence of gastrointestinal bleeding and found fair evidence that aspirin increases the incidence of hemorrhagic strokes.

Although the benefits of aspirin outweigh the harms for persons with an increased risk of CHD, the harms may exceed the benefits for those at low risk of CHD.

Aspirin recommended in those with ≥ 3% risk of heart attack within 5 years.
Annals of Internal Medicine

As patients may have different views, physicians should discuss the benefits and harms of aspirin with each patient before deciding to use aspirin to prevent heart attacks.

Assessing a person's age, sex, blood pressure, cholesterol levels, and whether he or she smokes or has diabetes can estimate overall risk for coronary heart disease.

The balance of benefits and harms of aspirin for preventing CHD shifts toward benefit with increasing risk for CHD.

The benefits of aspirin are clearest for those who have 3% or greater chance of suffering a heart attack within 5 years, according to the USPSTF.

"Aspirin therapy is powerful, and clinicians and patients need to discuss the role of aspirin therapy in combating CHD," said John M. Eisenberg, director of the Agency for Healthcare Research and Quality (AHRQ), which sponsors the USPSTF.

"This recommendation presents an ideal opportunity for clinicians to work with patients to determine the most appropriate therapy."

Ann Intern Med 2002; 137(2)
15 January 2002

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us